Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)
China flag China · Delayed Price · Currency is CNY
23.62
+0.62 (2.70%)
Oct 23, 2026, 3:04 PM CST

SHE:300683 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
138.49648.33419.15510.22748.48184.05
Short-Term Investments
-2.234.560.3142.75491.39
Trading Asset Securities
230.22170.63449.69578.71144.04514.4
Cash & Short-Term Investments
368.7821.19873.41,0891,0351,190
Cash Growth
-47.01%-5.98%-19.81%5.21%-12.99%18.99%
Accounts Receivable
278.62298.58300.78254.58233.21264.48
Other Receivables
3.750.1100-3.18
Receivables
282.37298.69300.78254.58233.21270.15
Inventory
84.3682.94108.98117.41120.1871.65
Other Current Assets
457.5627.0523.1826.9855.4750.88
Total Current Assets
1,1931,2301,3061,4881,4441,583
Property, Plant & Equipment
619.17658.14729.69734.56654.23519.63
Long-Term Investments
40.2542.8516.5827.0888.8965.29
Goodwill
178.59178.59263.59263.59302.15316.17
Other Intangible Assets
212.47229.09253.44276.8890.3790
Long-Term Deferred Tax Assets
133.07120.52119.94109.4780.5971.64
Long-Term Deferred Charges
30.2234.5134.4931.962.622.39
Other Long-Term Assets
7.8982.97212.5739.5143.8749.87
Total Assets
2,4152,5772,9372,9712,7072,698

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
32.1633.1364.3552.0858.0551.72
Accrued Expenses
12.726379.1159.8646.5146.42
Short-Term Debt
6.767.067.227.3230.0333.04
Current Portion of Long-Term Debt
24.5721.3714.8314.667.313.21
Current Portion of Leases
-0.935.124.80.71.87
Current Income Taxes Payable
6.532.173.872.842.464.52
Current Unearned Revenue
59.8253.7777.5411697.9966.38
Other Current Liabilities
126.77127.41111.2188.5841.6842.09
Total Current Liabilities
269.33308.85363.26346.15284.73249.25
Long-Term Debt
--11.5226.3240.9248.17
Long-Term Leases
3.083.95.3610.42.593.64
Long-Term Unearned Revenue
83.3383.0484.2530.4727.922.59
Long-Term Deferred Tax Liabilities
9.8711.3514.7416.4813.117.25
Other Long-Term Liabilities
--45.9245.922.4523.56
Total Liabilities
365.61407.14525.05475.73371.7354.46

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
130.89130.89130.89130.89122.1122.1
Additional Paid-In Capital
1,8371,8371,8371,8371,5571,557
Retained Earnings
73.44192.71423.98510.34631.16645.19
Total Common Equity
2,0422,1612,3922,4782,3102,324
Minority Interest
6.978.8719.817.3724.7918.65
Shareholders' Equity
2,0492,1692,4122,4962,3352,343
Total Liabilities & Equity
2,4152,5772,9372,9712,7072,698

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
34.4133.2644.0563.581.5589.92
Net Cash (Debt)
334.29787.93829.351,026953.731,100
Net Cash Growth
-51.17%-4.99%-19.14%7.55%-13.29%10.72%
Net Cash Per Share
2.556.036.347.907.4810.34
Filing Date Shares Outstanding
130.83130.89130.89130.89122.1122.1
Total Common Shares Outstanding
130.83130.89130.89130.89122.1122.1
Working Capital
923.66921.02943.071,1421,1591,333
Book Value Per Share
15.6116.5118.2718.9318.9219.04
Tangible Book Value
1,6511,7531,8751,9381,9181,918
Tangible Book Value Per Share
12.6213.3914.3214.8015.7115.71
Buildings
-503.22500.14500.38398.72350.14
Machinery
-521.43528.75480.61339.05291.83
Construction In Progress
-7.3611.022.99120.9934.27